125 related articles for article (PubMed ID: 35157032)
61. Susceptibility to cervical cancer: an overview.
de Freitas AC; Gurgel AP; Chagas BS; Coimbra EC; do Amaral CM
Gynecol Oncol; 2012 Aug; 126(2):304-11. PubMed ID: 22484226
[TBL] [Abstract][Full Text] [Related]
62. Cervical Carcinogenesis and Immune Response Gene Polymorphisms: A Review.
Mehta AM; Mooij M; Branković I; Ouburg S; Morré SA; Jordanova ES
J Immunol Res; 2017; 2017():8913860. PubMed ID: 28280748
[TBL] [Abstract][Full Text] [Related]
63. Genome-wide association study and functional follow-up identify 14q12 as a candidate risk locus for cervical cancer.
Ramachandran D; Dennis J; Fachal L; Schürmann P; Bousset K; Hülse F; Mao Q; Wang Y; Jentschke M; Böhmer G; Strauß HG; Hirchenhain C; Schmidmayr M; Müller F; Runnebaum I; Hein A; Stübs F; Koch M; Ruebner M; Beckmann MW; Fasching PA; Luyten A; Dürst M; Hillemanns P; Easton DF; Dörk T
Hum Mol Genet; 2022 Aug; 31(15):2483-2497. PubMed ID: 35157032
[TBL] [Abstract][Full Text] [Related]
64. Genome-wide association study of HPV-associated cervical cancer in Japanese women.
Miura K; Mishima H; Kinoshita A; Hayashida C; Abe S; Tokunaga K; Masuzaki H; Yoshiura K
J Med Virol; 2014 Jul; 86(7):1153-8. PubMed ID: 24700089
[TBL] [Abstract][Full Text] [Related]
65. Genome-wide association study of cervical cancer suggests a role for ARRDC3 gene in human papillomavirus infection.
Takeuchi F; Kukimoto I; Li Z; Li S; Li N; Hu Z; Takahashi A; Inoue S; Yokoi S; Chen J; Hang D; Kuroda M; Matsuda F; Mizuno M; Mori S; Wu P; Tanaka N; Matsuo K; Kamatani Y; Kubo M; Ma D; Shi Y
Hum Mol Genet; 2019 Jan; 28(2):341-348. PubMed ID: 30412241
[TBL] [Abstract][Full Text] [Related]
66. Significant association between IL10-1082/-819 and TNF-308 haplotypes and the susceptibility to cervical carcinogenesis in women infected by Human papillomavirus.
Chagas BS; Lima RCP; Paiva Júnior SSL; Silva RCO; Cordeiro MN; Silva Neto JDC; Batista MVA; Silva AJD; Gurgel APAD; Freitas AC
Cytokine; 2019 Jan; 113():99-104. PubMed ID: 29935877
[TBL] [Abstract][Full Text] [Related]
67. Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
Ekanayake Weeramange C; Shu D; Tang KD; Batra J; Ladwa R; Kenny L; Vasani S; Frazer IH; Dolcetti R; Ellis JJ; Sturm RA; Leo P; Punyadeera C
Cancer; 2022 May; 128(10):1937-1947. PubMed ID: 35176174
[TBL] [Abstract][Full Text] [Related]
68. Genomic Risk Factors for Cervical Cancer.
Ramachandran D; Dörk T
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680286
[TBL] [Abstract][Full Text] [Related]
69. Genomic Characterization and Therapeutic Targeting of HPV Undetected Cervical Carcinomas.
Ruiz FJ; Sundaresan A; Zhang J; Pedamallu CS; Halle MK; Srinivasasainagendra V; Zhang J; Muhammad N; Stanley J; Markovina S; Tiwari HK; Grigsby PW; Krakstad C; Schwarz JK; Ojesina AI
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572780
[TBL] [Abstract][Full Text] [Related]
70. Association of genomic variants at PAX8 and PBX2 with cervical cancer risk.
Ramachandran D; Wang Y; Schürmann P; Hülse F; Mao Q; Jentschke M; Böhmer G; Strauß HG; Hirchenhain C; Schmidmayr M; Müller F; Runnebaum I; Hein A; Koch M; Ruebner M; Beckmann MW; Fasching PA; Luyten A; Dürst M; Hillemanns P; Dörk T
Int J Cancer; 2021 Apr; ():. PubMed ID: 33905146
[TBL] [Abstract][Full Text] [Related]
71. Genetic variation in cervical preinvasive and invasive disease: a genome-wide association study.
Bowden SJ; Bodinier B; Kalliala I; Zuber V; Vuckovic D; Doulgeraki T; Whitaker MD; Wielscher M; Cartwright R; Tsilidis KK; Bennett P; Jarvelin MR; Flanagan JM; Chadeau-Hyam M; Kyrgiou M;
Lancet Oncol; 2021 Apr; 22(4):548-557. PubMed ID: 33794208
[TBL] [Abstract][Full Text] [Related]
72. Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.
Rashkin SR; Graff RE; Kachuri L; Thai KK; Alexeeff SE; Blatchins MA; Cavazos TB; Corley DA; Emami NC; Hoffman JD; Jorgenson E; Kushi LH; Meyers TJ; Van Den Eeden SK; Ziv E; Habel LA; Hoffmann TJ; Sakoda LC; Witte JS
Nat Commun; 2020 Sep; 11(1):4423. PubMed ID: 32887889
[TBL] [Abstract][Full Text] [Related]
73. Association of genomic variants at the human leukocyte antigen locus with cervical cancer risk, HPV status and gene expression levels.
Ramachandran D; Schürmann P; Mao Q; Wang Y; Bretschneider LM; Speith LM; Hülse F; Enßen J; Bousset K; Jentschke M; Böhmer G; Strauß HG; Hirchenhain C; Schmidmayr M; Tarbiat J; Runnebaum I; Dürst M; Hein A; Koch M; Ruebner M; Ekici A; Beckmann MW; Fasching PA; Luyten A; Petry KU; Hillemanns P; Dörk T
Int J Cancer; 2020 Nov; 147(9):2458-2468. PubMed ID: 32580243
[TBL] [Abstract][Full Text] [Related]
74. HPV-negative Tumors in a Swedish Cohort of Cervical Cancer.
Kaliff M; Karlsson MG; Sorbe B; Bohr Mordhorst L; Helenius G; Lillsunde-Larsson G
Int J Gynecol Pathol; 2020 May; 39(3):279-288. PubMed ID: 31206367
[TBL] [Abstract][Full Text] [Related]
75. HPV negative cervical cancers and primary HPV screening.
Tjalma W
Facts Views Vis Obgyn; 2018 Jun; 10(2):107-113. PubMed ID: 31110650
[TBL] [Abstract][Full Text] [Related]
76. Genetic susceptibility to cervical neoplasia.
Brown MA; Leo PJ
Papillomavirus Res; 2019 Jun; 7():132-134. PubMed ID: 30954690
[TBL] [Abstract][Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
